Masuyama and colleagues recently showed that the knockdown of PXR in ovarian cancer cells strongly inhibited the augmentation of MDR1 expression and PXR-mediated transcription by PXR ligands and significantly enhanced cell growth inhibition and apoptosis in the presence of paclitaxel or cisplatin56. This evidence concerns the gene NR1I2 and ovarian cancer.